Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Cow (Bovine) Polyclonal HTRA1 Primary Antibody for ICC, IF - ABIN4320643
Clawson, Bui, Xin, Wang, Pan: Intracellular localization of the tumor suppressor HtrA1/Prss11 and its association with HPV16 E6 and E7 proteins. in Journal of cellular biochemistry 2008
Show all 2 Pubmed References
Human Polyclonal HTRA1 Primary Antibody for ICC, IF - ABIN4320641
Wang, Eckert, Zomorrodi, Xin, Pan, Shearer, Weisz, Maranus, Clawson: Down-regulation of HtrA1 activates the epithelial-mesenchymal transition and ATM DNA damage response pathways. in PLoS ONE 2012
Human Polyclonal HTRA1 Primary Antibody for IF, IHC (p) - ABIN388127
Hu, Carozza, Klein, Nantermet, Luk, Crowl: Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage. in The Journal of biological chemistry 1999
Show all 5 Pubmed References
Human Polyclonal HTRA1 Primary Antibody for IHC (p), WB - ABIN388128
Chamberland, Wang, Jones, Collins-Racie, LaVallie, Huang, Liu, Morris, Flannery, Yang: Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivo. in The Journal of biological chemistry 2009
Show all 5 Pubmed References
HtrA1 is indispensable for dorsoventral patterning in early zebrafish embryogenesis and serves as a key upstream regulator of FGF signaling through the control of FGF levels.
Our data point to a yet unexpected effect of decreased HTRA1 expression on drusen pathogenesis. Thus not only a higher HTRA1 expression, but an imbalance of HTRA1 might be disease-relevant.
Tests for association revealed a variant in the promoter region of HTRA1 and two variants in the 5'-UTR (show UTS2R Antibodies) of ARMS2 (show ARMS2 Antibodies) to be associated with drusen.
As in humans, one variant within LOC387715/ARMS2 (show ARMS2 Antibodies) and one in HTRA1 were significantly associated with age-related macular degeneration.
These data implicate HTRA1 as a negative regulator of mesenchymal stem cell adipogenesis.
These results suggest that the initiation stage of polypoidal choroidal vasculopathy is mediated by proteolytic degradation of extracellular matrix proteins attributable to increased HTRA1 activity
The findings of the present study provide evidence that CFH (show CFH Antibodies) gene variants and ARMS2 (show ARMS2 Antibodies)/HTRA1 genes play a major role in the genetic susceptibility to AMD (show AMD1 Antibodies) in a Greek population. These findings are of direct relevance for disease and help mapping the genetic chart of AMD (show AMD1 Antibodies).
The function of the binding between MIF (show AMH Antibodies) and HTRA1 is to inhibit the proteolytic activity of HTRA1.
Results show that HTRA1 is epigenetically silenced in HCT116 colon carcinoma cells and during early stages of tumorigenesis in a mouse model of intestinal cancer. Downregulation of HTRA1 causes a multiple phenotypes that are hallmarks of cancer cells including increased proliferation of mouse embryonic fibroblasts, as well as chromosome and centrosome amplifications.
High HTRA1 expression is associated with cervical cell proliferation.
Data indicate HtrA serine peptidase 1 (HTRA1) involvement in Age-related macular degeneration (AMD (show AMD1 Antibodies)) pathogenesis.
Variants in HTRA1 are not associated with age-related macular degeneration.
Results show the heterozygous missense mutations p.G283E, p.P285L, p.R302Q, and p.T319I in the HTRA1 gene in 8 patients with symptomatic cerebral small vessel disease; mutant HTRA1s observed in manifesting heterozygotes might result in an impaired HTRA1 activation cascade of HTRA1 or be unable to form stable trimers
FN and HtrA1 are localized in the placental key growth zones suggesting a pivotal role in maintaining the balance among the molecules involved in the placental development and differentiation
transfection of cells with a constitutively active rapamycin-resistant p70S6K (show RPS6KB1 Antibodies) mutant could restore the mineralizing capacity of HtrA1-deficient mouse adipose-derived stromal cells.
Increased expressions of Tgf-beta1 (show TGFB1 Antibodies), p-Smad2 (show SMAD2 Antibodies)/3 and HtrA1 were detected in the articular chondrocytes of knee joints in models of osteoarthritis.
In mouse brain tissue and embryonic fibroblasts there is a facilitating role of HtrA1 in TGF-beta (show TGFB1 Antibodies) pathway activation.
HtrA1 plays important roles in the differentiation of trophoblasts from Tpbpa-positive precursors in the ectoplacental cone
The HtrA1 overexpression and mainstream cigarette smoke can independently lead to CNV. The HtrA1 gene is a strong risk factor for wet AMD (show AMD1 Antibodies)
the inhibitory effect of IFN-gamma (show IFNG Antibodies) on HTRA1 expression was evidenced in collagen-induced arthritis (CIA (show NCOA5 Antibodies)) mouse models and in human RA synovial cells.
Serine protease HTRA1 antagonizes transforming growth factor-beta signaling by cleaving its receptors and loss of HTRA1 in vivo enhances bone formation.
Data show that HtrA1 is produced during osteoclastogenesis, and negatively regulates osteoblast differentiation, osteoblast differentiation and BMP2 (show BMP2 Antibodies)-induced Smad1 (show SMAD1 Antibodies)/5/8, ERK1/2 (show MAPK1/3 Antibodies) and p38 (show CRK Antibodies) phosphorylation in pre-osteoblasts.
This study offers new insights into the regulation of HTRA-1 expression via LPS (show TLR4 Antibodies)/TLR-4 (show TLR4 Antibodies) and the role of HTRA-1 in rheumatoid arthrisis pathogenesis.
suggest a critical role for LRP1 (show LRP1 Antibodies) in maintaining the integrity of vessels by regulating protease activity as well as matrix deposition by modulating HtrA1 and connective tissue growth factor (show CTGF Antibodies) protein levels.
The results are consistent with a mechanism by which xHtrA1, through cleaving proteoglycans, releases cell-surface-bound Fibroblast Growth Factors (FGF) ligands and stimulates long-range FGF signaling.
This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7.
HtrA serine peptidase 1
, high-temperature requirement A serine peptidase 1A
, serine protease 11
, serine protease HTRA1A
, high-temperature requirement A serine peptidase 1B
, serine protease HTRA1B
, high temperature required A1
, Serine protease HTRA1
, high-temperature requirement A serine peptidase 1
, protease, serine, 11 (IGF binding)
, serine protease HTRA1
, insulin-like growth factor binding protein 5 protease
, protease, serine, 11 (Igf binding)
, IGF binding
, protease, serine, 11
, protease serine 11
, High-temperature requirement A serine peptidase 1
, Serine protease 11